<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22974" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Home Oxygen Therapy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shebl</surname>
            <given-names>Eman</given-names>
          </name>
          <aff>Zagazig University Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Modi</surname>
            <given-names>Pranav</given-names>
          </name>
          <aff>DY Patil Hospital, Navi Mumbai, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cates</surname>
            <given-names>Terry D.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Eman Shebl declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pranav Modi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Terry Cates declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22974.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>For patients with chronic pulmonary or cardiac diseases, there is often a need for oxygen therapy to continue after discharge from hospitalization. Providing oxygen for patients at home has many benefits when given appropriately. This activity describes the indications of home oxygen therapy and highlights the role of the interprofessional team in the management of patients with lung disorders that necessitates home oxygen.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for home oxygen therapy.</p></list-item><list-item><p>Describe the equipment needed for home oxygen therapy.</p></list-item><list-item><p>Outline the complications of home oxygen therapy.</p></list-item><list-item><p>Describe the importance of improving care coordination among interprofessional team members to improve outcomes for patients with lung disease needing home oxygen therapy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22974&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22974">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22974.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>For patients with chronic pulmonary or cardiac diseases, there is often a need for oxygen therapy to continue after discharge from&#x000a0;hospitalization.&#x000a0;Providing oxygen for patients at home has many benefits when given appropriately.</p>
        <p>&#x000a0;Oxygen supplementation at home includes:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Long-term oxygen therapy (LTOT)</italic>&#x000a0;in which&#x000a0;oxygen is delivered&#x000a0;for patients with chronic hypoxemia, for at least 15 hours daily.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Ambulatory oxygen therapy (AOT):</italic> Oxygen supplementation during exercise and daily activities for patients who are not hypoxemic at rest but who develop hypoxemia on exercise.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Nocturnal oxygen therapy (NOT) </italic>in which oxygen administered overnight alone with no oxygen therapy during daytime hours.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Short burst oxygen</italic> in which&#x000a0;a brief&#x000a0;and intermittent oxygen supplementation used as needed in the absence of hypoxemia.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Palliative oxygen therapy (POT):</italic> The use of oxygen for relieving breathlessness in advanced or life-limiting disease in the absence of known hypoxemia.</p>
          </list-item>
        </list>
        <p>These methods of oxygen delivery at home have different degrees of supporting evidence.<xref ref-type="bibr" rid="article-22974.r1">[1]</xref></p>
      </sec>
      <sec id="article-22974.s3" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold>Indications for Long-Term Oxygen Therapy (LTOT)</bold>
</p>
        <list list-type="order">
          <list-item>
            <p><bold><italic toggle="yes">Chronic Obstructive Pulmonary Disease (COPD)</italic></bold>
<list list-type="bullet"><list-item><p>LTOT is indicated for patients with chronic obstructive pulmonary disease (COPD) when:
<list list-type="bullet"><list-item><p>A resting PaO2&#x000a0;= 7.3 kPa (55 mm Hg) or SaO2&#x000a0;88% or less while being at rest in a stable clinical condition</p></list-item><list-item><p>A resting PaO2&#x000a0;= 8.0 kPa (59 mm Hg) or SaO2 89% or less if there is evidence of cor pulmonale, right heart failure or polycythemia&#x000a0;(hematocrit greater than 55%) while being&#x000a0; in a stable clinical condition<xref ref-type="bibr" rid="article-22974.r2">[2]</xref></p></list-item><list-item><p>Many previous studies showed a survival benefit of LTOT in COPD patients with chronic hypoxemia.<xref ref-type="bibr" rid="article-22974.r3">[3]</xref><xref ref-type="bibr" rid="article-22974.r4">[4]</xref>&#x000a0;Also, with COPD, LTOT may improve patient outcome measures other than survival benefits, including quality of life, depression, cognitive function, exercise capacity, and hospital admission rate.<xref ref-type="bibr" rid="article-22974.r4">[4]</xref></p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Interstitial Lung Disease (ILD)</bold></italic>
<list list-type="bullet"><list-item><p>Patients with severe ILD may develop chronic hypoxemia, which may lead to reduced tissue oxygenation with many subsequent complications and worsen prognosis. The use of LTOT in patients with ILD may improve survival and prevent complications. There are no randomized controlled trials (RCTs) reporting the LTOT effects in ILD, and so, recommendations for LTOT are extrapolated from evidence in COPD patients.<xref ref-type="bibr" rid="article-22974.r2">[2]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Pulmonary Hypertension</bold></italic>
<list list-type="bullet"><list-item><p>There is no evidence of LTOT survival benefits in patients with pulmonary hypertension, except pulmonary hypertension due to COPD. But LTOT in pulmonary hypertension may improve tissue oxygenation and prevent complications due to chronic hypoxemia.<xref ref-type="bibr" rid="article-22974.r2">[2]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Cystic Fibrosis (CF)</bold></italic>
<list list-type="bullet"><list-item><p>Severe CF patients may develop chronic hypoxemia. LTOT in patients with CF may lead to survival improvement and prevent complications caused by chronic hypoxemia, but no studies examined the use of LTOT in CF patients. Recommendations for LTOT in these patients are&#x000a0;extrapolated from evidence in COPD patients.<xref ref-type="bibr" rid="article-22974.r5">[5]</xref><xref ref-type="bibr" rid="article-22974.r2">[2]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes"><bold>Advanced Cardiac Failure</bold></italic>
<list list-type="bullet"><list-item><p>There are no studies on the effects of LTOT in patients with chronic heart failure. Using LTOT in patients with advanced cardiac failure and resting hypoxemia may lead to an improvement in tissue oxygenation and preventing complications due to hypoxemia.<xref ref-type="bibr" rid="article-22974.r5">[5]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22974.s4" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There is only one absolute contraindication to home oxygen therapy. Home oxygen therapy is not indicated in patients who continue smoking cigarettes because of the significant risk of fire.<xref ref-type="bibr" rid="article-22974.r6">[6]</xref>&#x000a0;Similarly, oxygen cylinders or supplies should be kept away from the flames or electrical circuits.</p>
      </sec>
      <sec id="article-22974.s5" sec-type="Equipment">
        <title>Equipment</title>
        <p>&#x000a0;Many types of devices are available for home oxygen use. These include concentrators, liquid systems, cylinders, and generators. The choice of an oxygen delivery system depends on the clinical status of the patient and the needed concentration of inspired oxygen and patient tolerance to the device used.</p>
        <p>Typical routes for home oxygen therapy include:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">The low-flow nasal cannula is one option,</italic> which supplies a low flow of oxygen (1 to 6 liter per minute). For each liter per minute of oxygen flow, about 3% to 4% is added to the oxygen concentration. Oxygen delivered by nasal cannula to the nasopharynx mixes with room air. Consequently, the concentration of oxygen by nasal cannula varies depending upon the patient's respiratory rate, tidal volume, oxygen flow rate, and extent of mouth breathing.<xref ref-type="bibr" rid="article-22974.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Simple oxygen masks</italic> used to supply a flow of oxygen rates between 6 and 10 L per minute with oxygen concentrations between 35% and 50%, and this depends on the patient's respiratory rate and the mask fit.<xref ref-type="bibr" rid="article-22974.r8">[8]</xref>&#x000a0;In a simple mask, oxygen&#x000a0;delivery is through a small-bore tube connected at the base of the mask. Exhaled gas escapes through holes on each side of the mask. Room air enters through these holes and mixes with oxygen, an oxygen flow rate greater than 5 L per minute&#x000a0;is needed to prevent CO2 rebreathing.<xref ref-type="bibr" rid="article-22974.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Venturi&#x000a0;masks,</italic>&#x000a0;which&#x000a0;allow for a fixed O2%, are available&#x000a0;for delivery of controlled oxygen concentrations of 24% to 40%. May benefit patients with hypercapnic respiratory failure requiring LTOT.<xref ref-type="bibr" rid="article-22974.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Other interfaces exist that allow minimal head contact but no facial contact.<xref ref-type="bibr" rid="article-22974.r7">[7]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22974.s6" sec-type="Preparation">
        <title>Preparation</title>
        <p>
<bold>Patient Screening for LTOT Requirement</bold>
</p>
        <p>A pulse oximeter is widely available and can be useful&#x000a0;for screening patients who might be indicated for LTOT.<xref ref-type="bibr" rid="article-22974.r5">[5]</xref> Studies showed that using the SpO2&#x000a0;level equal to 92% has 100% sensitivity and specificity of only 69% for identifying patients with a PaO2 less than 7.3 kPa.&#x000a0;Stable patients with oxygen saturation (SpO2) equal to 92% at rest should be referred for a blood gas evaluation, and assessment for LTOT need. Stable patients with clinical evidence of peripheral edema, hematocrit equal to 55% or pulmonary hypertension with oxygen saturation (SpO2) equal to 94% at rest should be referred for a blood gas evaluation, and assessment for LTOT need.<xref ref-type="bibr" rid="article-22974.r10">[10]</xref><xref ref-type="bibr" rid="article-22974.r5">[5]</xref></p>
        <p>
<bold>Follow-up of LTOT Patients</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Follow-up should occur at three months after initiating LTOT, to ensure LTOT is still necessary.</p>
          </list-item>
          <list-item>
            <p>Patients receiving LTOT should have follow-up at 6 to 12 months after the first 3-month follow-up.<xref ref-type="bibr" rid="article-22974.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22974.s7" sec-type="Complications">
        <title>Complications</title>
        <p>There are potential toxicities in patients administered oxygen in high concentrations (above 50%) for long periods like atelectasis, oxidative stress, and peripheral vasoconstriction, but the benefits outweigh the risks. Uncontrolled oxygen delivery may lead to a worsening of hypercapnia in patients with chronic obstructive pulmonary disease. It is advised to target the SpO2&#x000a0;to 90% to 92% to prevent tissue hypoxia while minimizing any side effects, which might be associated with excessive oxygen supplementation.</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients should be made aware of the dangers of using home oxygen in the presence of any naked flame, such as cookers and candles. Oxygen cylinders should be at least 5 feet away from naked flames, a heat source, or electrical devices.</p>
          </list-item>
          <list-item>
            <p>There is a significant risk of fire associated with smoking while using home oxygen therapy. Smoking cessation should be advocated. And a written education plan should be given to patients before ordering home oxygen.<xref ref-type="bibr" rid="article-22974.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>The skin around the facemask or nasal cannula can get irritated or bruised if the mask fits tightly.</p>
          </list-item>
          <list-item>
            <p>The nasal mucosa might become dry, and nosebleeds can occur.</p>
          </list-item>
          <list-item>
            <p>Morning headache or tiredness can occur with oxygen therapy.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22974.s8" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A&#x000a0;respiratory&#x000a0;therapist&#x000a0;can&#x000a0;evaluate&#x000a0;and assist patients with their home oxygen needs. The respiratory therapist can provide&#x000a0;expertise&#x000a0;in the various&#x000a0;types of&#x000a0;home oxygen delivery devices and provide&#x000a0;ongoing&#x000a0;assessment of the patient. Patient compliance&#x000a0;can&#x000a0;be maximized&#x000a0;by selecting the&#x000a0;appropriate&#x000a0;device.<xref ref-type="bibr" rid="article-22974.r10">[10]</xref>&#x000a0;Before, referring patients to home oxygen evaluation services,&#x000a0;patients should receive both written and verbal information.<xref ref-type="bibr" rid="article-22974.r1">[1]</xref>&#x000a0;[Level&#x000a0;4]</p>
      </sec>
      <sec id="article-22974.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22974&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22974">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22974/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22974">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22974.s10">
        <title>References</title>
        <ref id="article-22974.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suntharalingam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Annandale</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davey</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fielding</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gibbons</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hardinge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hippolyte</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Knowles</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>MacNee</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pollington</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vora</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wijesinghe</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>British Thoracic Society quality standards for home oxygen use in adults.</article-title>
            <source>BMJ Open Respir Res</source>
            <year>2017</year>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>e000223</fpage>
            <pub-id pub-id-type="pmid">29018527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hardinge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Annandale</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bourne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hippolyte</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Knowles</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>MacNee</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>McDonnell</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pye</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suntharalingam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vora</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>T</given-names>
              </name>
              <collab>British Thoracic Society Home Oxygen Guideline Development Group</collab>
              <collab>British Thoracic Society Standards of Care Committee</collab>
            </person-group>
            <article-title>British Thoracic Society guidelines for home oxygen use in adults.</article-title>
            <source>Thorax</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>70 Suppl 1</volume>
            <fpage>i1</fpage>
            <page-range>i1-43</page-range>
            <pub-id pub-id-type="pmid">25870317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanni</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Guiotoko</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Godoy</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Godoy</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Influence of the oxygen delivery system on the quality of life of patients with chronic hypoxemia.</article-title>
            <source>J Bras Pneumol</source>
            <year>2007</year>
            <season>Mar-Apr</season>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-7</page-range>
            <pub-id pub-id-type="pmid">17724535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calverley</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Brezinova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Catterall</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Flenley</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>The effect of oxygenation on sleep quality in chronic bronchitis and emphysema.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1982</year>
            <month>Aug</month>
            <volume>126</volume>
            <issue>2</issue>
            <fpage>206</fpage>
            <page-range>206-10</page-range>
            <pub-id pub-id-type="pmid">7103244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hardinge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suntharalingam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>T</given-names>
              </name>
              <collab>British Thoracic Society</collab>
            </person-group>
            <article-title>Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults.</article-title>
            <source>Thorax</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>70</volume>
            <issue>6</issue>
            <fpage>589</fpage>
            <page-range>589-91</page-range>
            <pub-id pub-id-type="pmid">25918120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Home oxygen and domestic fires.</article-title>
            <source>Breathe (Sheff)</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-12</page-range>
            <pub-id pub-id-type="pmid">26306099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paul</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Otvos</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Comparison of nasal cannulas and the OxyArm in patients requiring chronic domiciliary oxygen therapy.</article-title>
            <source>Can Respir J</source>
            <year>2006</year>
            <season>Nov-Dec</season>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>421</fpage>
            <page-range>421-6</page-range>
            <pub-id pub-id-type="pmid">17149460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Myers</surname>
                <given-names>TR</given-names>
              </name>
              <collab>American Association for Respiratory Care (AARC)</collab>
            </person-group>
            <article-title>AARC Clinical Practice Guideline: selection of an oxygen delivery device for neonatal and pediatric patients--2002 revision &#x00026; update.</article-title>
            <source>Respir Care</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>707</fpage>
            <page-range>707-16</page-range>
            <pub-id pub-id-type="pmid">12078654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sandstedt</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Rebreathing during oxygen treatment with face mask. The effect of oxygen flow rates on ventilation.</article-title>
            <source>Acta Anaesthesiol Scand</source>
            <year>1991</year>
            <month>May</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>289</fpage>
            <page-range>289-92</page-range>
            <pub-id pub-id-type="pmid">1906671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guyatt</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lacchetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goeree</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McKim</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Heels-Ansdell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2005</year>
            <month>Sep</month>
            <day>01</day>
            <volume>172</volume>
            <issue>5</issue>
            <fpage>573</fpage>
            <page-range>573-80</page-range>
            <pub-id pub-id-type="pmid">15901604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22974.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sj&#x000f6;berg</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The medical use of oxygen: a time for critical reappraisal.</article-title>
            <source>J Intern Med</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>274</volume>
            <issue>6</issue>
            <fpage>505</fpage>
            <page-range>505-28</page-range>
            <pub-id pub-id-type="pmid">24206183</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
